CONSOLIDATED BALANCE SHEETS (USD $)	Dec. 31, 2014	Dec. 31, 2013
Current assets
Cash	$ 13,858,798	$ 3,551,832
Prepaid drug product for testing	154,667	51,364
Other current assets	100,494	64,117
Total current assets	14,113,959	3,667,313
Fixed assets
Furniture, fixtures & equipment	123,410	0
Less Accumulated Depreciation	(10,284)	0
Property, Plant and Equipment, Net	113,126	0
Other assets
Technology licenses - related party	2,500,374	2,500,374
Less Accumulated Amortization	(1,249,481)	(1,088,856)
Intangible Assets, Net (Excluding Goodwill), Total	1,250,893	1,411,518
TOTAL ASSETS	15,477,978	5,078,831
Current liabilities
Accounts payable	41,026	76,109
Accounts payable - related party	100,450	0
Accrued expense	253,445	66,739
Accrued expense - related party	67,050	52,050
Accrued license payments - related party	100,000	100,000
Total current liabilities	561,971	294,898
Long term debt	0	0
TOTAL LIABILITIES	561,971	294,898
Shareholders' Equity
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	0	0
Common Stock, $.001 par value, 200,000,000 shares authorized 89,762,872 and 84,237,872 shares issued and outstanding as of 12/31/14 and 12/31/13, respectively	89,763	84,238
Additional paid in capital	34,743,489	20,096,991
Accumulated deficit	(19,917,245)	(15,397,296)
Total shareholders' equity	14,916,007	4,783,933
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY	$ 15,477,978	$ 5,078,831